- New Guidelines for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
-
Yoo H
- KMID: 2541452
- Korean J Med.
- 2023 Apr;98(2):64-72.
- doi: 10.3904/kjm.2023.98.2.64
Idiopathic pulmonary fibrosis (IPF) is the most common and fatal idiopathic interstitial pneumonia and is characterized by chronic progressive pulmonary fibrosis of indeterminate etiology. In 2018, the American Thoracic Society,... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between timing of intubation and mortality in patients with idiopathic pulmonary fibrosis
-
Bae E, Park J, Choi SM, Lee J, Lee SM, Lee HY
- KMID: 2540144
- Acute Crit Care.
- 2022 Nov;37(4):561-570.
- doi: 10.4266/acc.2022.00444
Background: Delayed intubation is associated with poor prognosis in patients with respiratory failure. However, the effect of delayed intubation in patients with idiopathic pulmonary fibrosis (IPF) remains unknown. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Adverse Effects of Air Pollution on Pulmonary Diseases
-
Ko UW, Kyung SY
- KMID: 2533835
- Tuberc Respir Dis.
- 2022 Oct;85(4):313-319.
- doi: 10.4046/trd.2022.0116
Environmental exposure to air pollution is known to have adverse effects on various organs. Air pollution has greater effects on the pulmonary system as the lungs are directly exposed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Granulocyte colony-stimulating factor in bronchoalveolar lavage fluid is a potential biomarker for prognostic prediction of idiopathic pulmonary fibrosis
-
Lee JU, Choi JS, Kim MK, Min SA, Park JS, Park CS
- KMID: 2533141
- Korean J Intern Med.
- 2022 Sep;37(5):979-988.
- doi: 10.3904/kjim.2021.442
Background/Aims: Neutrophilia is frequently observed in bronchoalveolar lavage fluid (BALF) of idiopathic pulmonary fibrosis (IPF) patients. Granulocyte colony-stimulating factor (G-CSF) is a potent neutrophil-activating glycoprotein. However, the clinical implications of... -
- CITED
-
- Close
- SHARE
-
- Close
- Indications for Lung Transplantation and Patient Selection
-
Son J, Shin C
- KMID: 2532345
- J Chest Surg.
- 2022 Aug;55(4):255-264.
- doi: 10.5090/jcs.22.057
Globally, thousands of patients undergo lung transplantation owing to end-stage lung disease each year. As lung transplantation evolves, recommendations and indications are constantly being updated. In 2021, the International Society... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Basic and Clinical Aspects of Rheumatoid Arthritis-associated Interstitial Lung Diseases
-
Lee H, Lee SI, Kim HO
- KMID: 2527544
- J Rheum Dis.
- 2022 Apr;29(2):61-70.
- doi: 10.4078/jrd.2022.29.2.61
Rheumatoid arthritis (RA) is a common autoimmune disease that mainly affects the joints and systemic organs, such as the skin, eyes, heart, gastrointestinal tract, and lungs. In particular, among various... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Pulmonary Fibrosis
-
Yoo SA, Park HE, Kim M, Park HJ
- KMID: 2527467
- Ann Dermatol.
- 2022 Apr;34(2):136-138.
- doi: 10.5021/ad.2022.34.2.136
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and lethal lung disease characterized by progressive dyspnea and irreversible loss of lung function. Pirfenidone is a novel anti-fibrotic and anti-inflammatory drug,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
-
Jegal Y, Park JS, Kim SY, Yoo H, Jeong SH, Song JW, Lee JH, Lee HL, Choi SM, Kim YW, Kim YH, Choi HS, Lee J, Uh ST, Kim TH, Kim SH, Lee WY, Kim YH, Lee Hk, Lee EJ, Heo EY, Yang SH, Kang HK, Chung MP, on behalf of Korea ILD Study Group
- KMID: 2528422
- Tuberc Respir Dis.
- 2022 Apr;85(2):185-194.
- doi: 10.4046/trd.2021.0123
Background: The Korea Interstitial Lung Disease Study Group has made a new nationwide idiopathic pulmonary fibrosis (IPF) registry because the routine clinical practice has changed due to new guidelines and... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and impact of airway diseases on clinical outcomes in idiopathic pulmonary fibrosis
-
Park H, Cho J, Lee J, Park YS, Lee CH, Lee SM, Yoo CG, Kim YW, Han SK, Choi SM
- KMID: 2527302
- Korean J Intern Med.
- 2022 Mar;37(2):387-397.
- doi: 10.3904/kjim.2021.025
Background/Aims: The prevalence and effects of airway diseases, including asthma, eosinophilic bronchitis (EB), chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) have not been thoroughly studied in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study
-
Hwang H, Lee JK, Choi SM, Lee YJ, Cho YJ, Yoon HI, Lee JH, Lee CT, Kim YW, Park JS
- KMID: 2527300
- Korean J Intern Med.
- 2022 Mar;37(2):366-376.
- doi: 10.3904/kjim.2020.559
Background/Aims: Pirfenidone slows the progression of idiopathic pulmonary fibrosis (IPF). We investigated its efficacy and safety in terms of dose and disease severity in real-world patients with IPF. Methods: This multicenter... -
- CITED
-
- Close
- SHARE
-
- Close
- The Value of 18 F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients
-
Yoon HY, Lee SH, Ha S, Ryu JS, Song JW
- KMID: 2521471
- J Korean Med Sci.
- 2021 Oct;36(41):e257.
- doi: 10.3346/jkms.2021.36.e257
Background: Several parameters are useful for assessing disease severity in idiopathic pulmonary fibrosis (IPF); however, the role of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) is not... -
- CITED
-
- Close
- SHARE
-
- Close
- Update in Diagnosis of Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormality
-
Nam BD, Hwang JH
- KMID: 2518610
- J Korean Soc Radiol.
- 2021 Jul;82(4):770-790.
- doi: 10.3348/jksr.2021.0072
Idiopathic pulmonary fibrosis (IPF), based on the 2018 international clinical practice guidelines, can be diagnosed with a usual interstitial pneumonia (UIP) pattern on high-resolution computed tomography (HRCT) and compatible clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Upregulation of receptor tyrosine kinase-like orphan receptor 2 in idiopathic pulmonary fibrosis
-
Son JH, Lee JU, Chin S, Go ES, Park JS, Shin HK, Chang HS, Park JS, Park CS
- KMID: 2517808
- Korean J Intern Med.
- 2021 Jul;36(4):914-923.
- doi: 10.3904/kjim.2019.270
Background/Aims: Receptor tyrosine kinase-like orphan receptor 2 (ROR2) is a major regulator of Wnt signaling, which is involved in fibroblast dysfunction. Because its role has not been evaluated in idiopathic... -
- CITED
-
- Close
- SHARE
-
- Close
- The effects of direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute exacerbation of interstitial lung disease
-
Lee JH, Park JH, Kim HJ, Kim HK, Jang JH, Kim YK, Park BS, Park SH, Kim IH, Kim SH, Heo W, Jang HJ
- KMID: 2516260
- Acute Crit Care.
- 2021 May;36(2):126-132.
- doi: 10.4266/acc.2021.00073
Background: Acute exacerbation of interstitial lung disease (AE-ILD) causes clinically significant deterioration and has an extremely poor prognosis with high mortality. Recently, several studies reported the effectiveness of direct hemoperfusion... -
- CITED
-
- Close
- SHARE
-
- Close
- Current and future treatment for idiopathic pulmonary fibrosis
-
Choi WI
- KMID: 2514980
- J Korean Med Assoc.
- 2021 Apr;64(4):256-263.
- doi: 10.5124/jkma.2021.64.4.256
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fibrosing interstitial lung disease, which is associated with a short survival rate. The decline in forced vital capacity in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis of idiopathic pulmonary fibrosis
-
Choi HS
- KMID: 2514979
- J Korean Med Assoc.
- 2021 Apr;64(4):248-255.
- doi: 10.5124/jkma.2021.64.4.248
Interstitial lung disease (ILD) is a group of diseases, involving the inflammation and fibrosis of the interstitium of the lung. ILD is classified according to whether or not the cause... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions
-
Choi WI
- KMID: 2514317
- Precis Future Med.
- 2021 Mar;5(1):31-40.
- doi: 10.23838/pfm.2020.00205
Idiopathic pulmonary fibrosis (IPF) was considered untreatable until the development of therapeutic drugs and diagnostic technology that made it possible to slow the progression of IPF. In 2014, pirfenidone and... -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Lung Abnormalities: What Radiologists Should Know
-
Chae KJ, Jin GY, Goo JM, Chung MJ
- KMID: 2513116
- Korean J Radiol.
- 2021 Mar;22(3):454-463.
- doi: 10.3348/kjr.2020.0191
Interstitial lung abnormalities (ILAs) are radiologic abnormalities found incidentally on chest CT that are potentially related to interstitial lung diseases. Several articles have reported that ILAs are associated with increased... -
- CITED
-
- Close
- SHARE
-
- Close
- Organoid Model in Idiopathic Pulmonary Fibrosis
-
Lee J, Kim JH, Hong SH, Yang SR
- KMID: 2513078
- Int J Stem Cells.
- 2021 Feb;14(1):1-8.
- doi: 10.15283/ijsc20093
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive- fibrosing disease characterized by extensive deposition of extracellular matrix (ECM), scarring of the lung parenchyma. Despite increased awareness of IPF, etiology and... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct hemoperfusion with polymyxin B-immobilized fiber column in a patient with acute exacerbation of idiopathic pulmonary fibrosis
-
Kim SY, Park JH, Kim HJ, Jang HJ, Kim HK, Kim SH, Lee JH
- KMID: 2510551
- Acute Crit Care.
- 2020 Nov;35(4):302-306.
- doi: 10.4266/acc.2020.00038
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterized by dyspnea and a worsening of the lung function. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are defined... -
- CITED
-
- Close
- SHARE
-
- Close
